InsidersTradesSigma
Explore the detailed record of transactions filed by Rubin Eyal, Chief Financial Officer. Insider active across 1 companies, notably Protalix BioTherapeutics, Inc.. Aggregated, 1 filings have been recorded. Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration
Eyal Rubin is Senior Vice President and Chief Financial Officer at Protalix BioTherapeutics, Inc. He oversees the company's financial operations, ensuring compliance and efficiency. His experience in finance is an asset to the company's strategy.